Share this
Sixth Street Invests in Blueprint Medicines
Forbius Agrees to Sell to Bristol Myers Squibb
Iconic Therapeutics Series C Financing
FibroGen Closes Largest Biotech IPO in 12 Years
T2 Biosystems IPO
Adamas Pharmaceuticals Initial Public Offering
Versartis $145 Million IPO
First US IPO of 2014 for GlycoMimetics